Equities

Regencell Bioscience Holdings Ltd

RGC:NAQ

Regencell Bioscience Holdings Ltd

Actions
  • Price (USD)25.43
  • Today's Change0.18 / 0.71%
  • Shares traded2.86k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 01 2021 15:09 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • RGC:NAQ price moved over -2.15% to 25.53
  • RGC:NAQ price rises above 15-day moving average to 25.37 at 10:01 GMT

Key statistics

As of last trade, Regencell Bioscience Holdings Ltd (RGC:NAQ) traded at 25.43, 323.83% above the 52 week low of 6.00 set on Aug 20, 2021.
52-week range
Today
6.00Aug 20 202159.00Aug 25 2021
Markit short selling activity
Low
Med
High
Open25.25
High25.43
Low25.25
Bid25.26
Offer25.41
Previous close25.25
Average volume22.36k
Shares outstanding12.97m
Free float2.57m
P/E (TTM)--
Market cap327.42m USD
EPS (TTM)-0.1065
USD
Data delayed at least 15 minutes, as of Dec 01 2021 15:09 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.